The cases with increased CD44+/CD24− tumour cell populations after PST showed high Ki-67 proliferation index in post-chemotherapy specimens (P=0.038) and tended to show high post-neoadjuvant therapy pathologic T (ypT) stage (P=0.091) and ER negativity (P=0.067). The gene discussed is MKI67; the disease is neoplasm.